Ototoxicity in Pediatric Hematopoietic Stem Cell Transplantation With High‐Dose Carboplatin: Identifying Modifiable Risk Factors Through the Inclusion of Younger Patients
Using criterion that allowed for the evaluation of very young children, this report demonstrates that cumulative dose of prior cisplatin, cumulative dose of carboplatin in the preparative regimen, and concomitant furosemide administration with carboplatin is associated with ototoxicity in cHSCT.
Authors
- Robert J. Hayashi (ORCID: https://orcid.org/0000-0002-1140-1139)
- Mary Claire McGlynn (ORCID: https://orcid.org/0000-0002-2600-6641)
- Ningying Wu (ORCID: https://orcid.org/0000-0002-0287-7362)
- Miranda L. Camet (ORCID: https://orcid.org/0000-0002-3784-7112)
- Susan S. Hayashi
- Anne Spence
Institutions
- Washington University in St. Louis (US)
- Jewish Hospital (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-07-20
- DOI
- https://doi.org/10.1002/pbc.31926
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.77